Vera Therapeutics (VERA) Current Leases (2022 - 2025)

Vera Therapeutics (VERA) has 4 years of Current Leases data on file, last reported at $549000.0 in Q4 2025.

• Quarterly Current Leases fell 62.98% year-over-year to $549000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $549000.0 (down 62.98% YoY) and the FY2025 annual result came in at $549000.0, down 62.98% from the prior year.
• Current Leases advanced to $549000.0 in Q4 2025, from $473000.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $2.7 million in Q3 2022 to a low of $473000.0 in Q3 2025.
• A 4-year average of $2.0 million and a median of $2.4 million in 2023 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2023 — Current Leases climbed 4.5% — and 2025, when it plunged 74.73%.
• Tracing VERA's Current Leases over 4 years: stood at $2.6 million in 2022, then retreated by 7.9% to $2.4 million in 2023, then slumped by 39.12% to $1.5 million in 2024, then slumped by 62.98% to $549000.0 in 2025.
• The last three Current Leases figures came in at $549000.0 (Q4 2025), $473000.0 (Q3 2025), and $855000.0 (Q2 2025), per Business Quant data.